1-4 of 4
Ti Shen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treatment of Primary Central Nervous System Lymphoma with a Combination of Intraventricular Administration of Rituximab and Systemic Chemotherapy.

Shujie Wang, MD, PhD, Wei Zhang, MD, Wei Lian, MD, Yongji Wu, MD, Nong Zou, MD, Tienan Zhu, MD, Daobin Zhou, MD, Ying Xu, MD, Ti Shen, MD, Yongqiang Zhao, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 4695.
https://doi.org/10.1182/blood.V108.11.4695.4695
Published: 2006
Journal Articles

Erythropoietin Response to Anemia Is Impaired in Patients with Hematologic Malignancies.

Ti Shen, Yuankai Shi, Jun Zhu, Bing Han
Journal: Blood
Blood (2005) 106 (11): 3744.
https://doi.org/10.1182/blood.V106.11.3744.3744
Published: 2005
Journal Articles

Results of Multicentre Phase IV Study of Rituximab in Combination with CHOP Chemotherapy in Patients with Previously Untreated Non-Hodgkin’s Lymphoma.

Ti Shen, Zhongzhen Guan, Zhixiang Shen, Yuankai She, Jun Zhu
Journal: Blood
Blood (2004) 104 (11): 4624.
https://doi.org/10.1182/blood.V104.11.4624.4624
Published: 2004
Journal Articles

Elevated Factor VIII: C Level Is a Risk Factor for Cerebral Infarction.

Baolai Hua, Jiraqi Pan, Yicheng Zhu, Xiaoli Liu, Liankai Fan, Liying Cun, Yongqiang Zhao, Ti Shen
Journal: Blood
Blood (2004) 104 (11): 4036.
https://doi.org/10.1182/blood.V104.11.4036.4036
Published: 2004